The modified blalock-taussig shunt using microporous expanded polytetrafluoroethylene (PTFE)

Area of Science:

• Cardiovascular Surgery
• Pediatric Cardiology
• Biomaterials Science

Background:

• Cyanotic congenital heart lesions often require palliative surgical interventions.
• The classical Blalock-Taussig shunt has limitations including subclavian artery compromise.

Purpose of the Study:

• To evaluate the efficacy and safety of a modified Blalock-Taussig shunt using expanded polytetrafluoroethylene (ePTFE) grafts.
• To assess the impact of graft diameter on shunt patency and patient outcomes.

Main Methods:

• Retrospective analysis of 36 modified Blalock-Taussig shunts in 34 patients (May 1977-February 1981).
• Utilized microporous expanded PTFE conduits of 4mm, 6mm, and 8mm diameters.
• Patient age ranged from neonates to 22 years, with 14 infants (<1 year old).

Main Results:

• Overall operative mortality was 5.5%.
• Six shunt failures (16.6%) occurred, exclusively in the 4mm graft group.
• Two-year actuarial shunt survival was 81.2%.

Conclusions:

• The modified Blalock-Taussig shunt with ePTFE is a viable option for cyanotic congenital heart disease.
• Graft diameter is a critical factor, with larger diameters (6mm and 8mm) demonstrating superior patency.
• This technique preserves subclavian artery integrity and simplifies surgical challenges compared to the classical shunt.